# Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation

> **NCT02379676** · PHASE4 · UNKNOWN · sponsor: **Kiyuk Chang** · enrollment: 38 (estimated)

## Conditions studied

- Endothelial Dysfunction
- Vascular Inflammation

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02379676
- **Lead sponsor:** Kiyuk Chang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2016-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02379676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02379676, "Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02379676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*